Global Non-oncology Biopharmaceuticals Market Research Report 2024, Forecast to 2032
Report Overview
Biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial. This report studies Non-oncology biopharmaceutical which are the drugs that are used in the treatment of various diseases rather than cancer.
The global Non-oncology Biopharmaceuticals market size was estimated at USD 295620 million in 2023 and is projected to reach USD 605884.61 million by 2032, exhibiting a CAGR of 8.30% during the forecast period.
North America Non-oncology Biopharmaceuticals market size was estimated at USD 88380.29 million in 2023, at a CAGR of 7.11% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Non-oncology Biopharmaceuticals market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non-oncology Biopharmaceuticals Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non-oncology Biopharmaceuticals market in any manner.
Global Non-oncology Biopharmaceuticals Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Sanofi
Johnson & Johnson
Pfizer
Novo Nordisk
Novartis
Merck
Teva
Eli Lilly
Bristol-Myers Squibb
GlaxoSmithKline
UCB Pharma
Amgen
AbbVie
Takeda
AstraZeneca
Mylan
LEO Pharma
Boehringer Ingelheim
Alexion Pharmaceuticals
Elusys Therapeutics
Swedish Orphan Biovitrum
Biogen
Market Segmentation (by Type)
Biologics
Biosimilars
Market Segmentation (by Application)
Immunology
Endocrinology
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-oncology Biopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Non-oncology Biopharmaceuticals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial. This report studies Non-oncology biopharmaceutical which are the drugs that are used in the treatment of various diseases rather than cancer.
The global Non-oncology Biopharmaceuticals market size was estimated at USD 295620 million in 2023 and is projected to reach USD 605884.61 million by 2032, exhibiting a CAGR of 8.30% during the forecast period.
North America Non-oncology Biopharmaceuticals market size was estimated at USD 88380.29 million in 2023, at a CAGR of 7.11% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Non-oncology Biopharmaceuticals market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non-oncology Biopharmaceuticals Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non-oncology Biopharmaceuticals market in any manner.
Global Non-oncology Biopharmaceuticals Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Sanofi
Johnson & Johnson
Pfizer
Novo Nordisk
Novartis
Merck
Teva
Eli Lilly
Bristol-Myers Squibb
GlaxoSmithKline
UCB Pharma
Amgen
AbbVie
Takeda
AstraZeneca
Mylan
LEO Pharma
Boehringer Ingelheim
Alexion Pharmaceuticals
Elusys Therapeutics
Swedish Orphan Biovitrum
Biogen
Market Segmentation (by Type)
Biologics
Biosimilars
Market Segmentation (by Application)
Immunology
Endocrinology
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Non-oncology Biopharmaceuticals Market
- Overview of the regional outlook of the Non-oncology Biopharmaceuticals Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-oncology Biopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Non-oncology Biopharmaceuticals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Non-oncology Biopharmaceuticals
1.2 Key Market Segments
1.2.1 Non-oncology Biopharmaceuticals Segment by Type
1.2.2 Non-oncology Biopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Non-oncology Biopharmaceuticals Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Non-oncology Biopharmaceuticals Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Global Non-oncology Biopharmaceuticals Sales by Manufacturers (2019-2024)
3.2 Global Non-oncology Biopharmaceuticals Revenue Market Share by Manufacturers (2019-2024)
3.3 Non-oncology Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Non-oncology Biopharmaceuticals Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Non-oncology Biopharmaceuticals Sales Sites, Area Served, Product Type
3.6 Non-oncology Biopharmaceuticals Market Competitive Situation and Trends
3.6.1 Non-oncology Biopharmaceuticals Market Concentration Rate
3.6.2 Global 5 and 10 Largest Non-oncology Biopharmaceuticals Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NON-ONCOLOGY BIOPHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 Non-oncology Biopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NON-ONCOLOGY BIOPHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-oncology Biopharmaceuticals Sales Market Share by Type (2019-2024)
6.3 Global Non-oncology Biopharmaceuticals Market Size Market Share by Type (2019-2024)
6.4 Global Non-oncology Biopharmaceuticals Price by Type (2019-2024)
7 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-oncology Biopharmaceuticals Market Sales by Application (2019-2024)
7.3 Global Non-oncology Biopharmaceuticals Market Size (M USD) by Application (2019-2024)
7.4 Global Non-oncology Biopharmaceuticals Sales Growth Rate by Application (2019-2024)
8 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET CONSUMPTION BY REGION
8.1 Global Non-oncology Biopharmaceuticals Sales by Region
8.1.1 Global Non-oncology Biopharmaceuticals Sales by Region
8.1.2 Global Non-oncology Biopharmaceuticals Sales Market Share by Region
8.2 North America
8.2.1 North America Non-oncology Biopharmaceuticals Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Non-oncology Biopharmaceuticals Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Non-oncology Biopharmaceuticals Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Non-oncology Biopharmaceuticals Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Non-oncology Biopharmaceuticals Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET PRODUCTION BY REGION
9.1 Global Production of Non-oncology Biopharmaceuticals by Region (2019-2024)
9.2 Global Non-oncology Biopharmaceuticals Revenue Market Share by Region (2019-2024)
9.3 Global Non-oncology Biopharmaceuticals Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Non-oncology Biopharmaceuticals Production
9.4.1 North America Non-oncology Biopharmaceuticals Production Growth Rate (2019-2024)
9.4.2 North America Non-oncology Biopharmaceuticals Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Non-oncology Biopharmaceuticals Production
9.5.1 Europe Non-oncology Biopharmaceuticals Production Growth Rate (2019-2024)
9.5.2 Europe Non-oncology Biopharmaceuticals Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Non-oncology Biopharmaceuticals Production (2019-2024)
9.6.1 Japan Non-oncology Biopharmaceuticals Production Growth Rate (2019-2024)
9.6.2 Japan Non-oncology Biopharmaceuticals Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Non-oncology Biopharmaceuticals Production (2019-2024)
9.7.1 China Non-oncology Biopharmaceuticals Production Growth Rate (2019-2024)
9.7.2 China Non-oncology Biopharmaceuticals Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Roche
10.1.1 Roche Non-oncology Biopharmaceuticals Basic Information
10.1.2 Roche Non-oncology Biopharmaceuticals Product Overview
10.1.3 Roche Non-oncology Biopharmaceuticals Product Market Performance
10.1.4 Roche Business Overview
10.1.5 Roche Non-oncology Biopharmaceuticals SWOT Analysis
10.1.6 Roche Recent Developments
10.2 Sanofi
10.2.1 Sanofi Non-oncology Biopharmaceuticals Basic Information
10.2.2 Sanofi Non-oncology Biopharmaceuticals Product Overview
10.2.3 Sanofi Non-oncology Biopharmaceuticals Product Market Performance
10.2.4 Sanofi Business Overview
10.2.5 Sanofi Non-oncology Biopharmaceuticals SWOT Analysis
10.2.6 Sanofi Recent Developments
10.3 Johnson and Johnson
10.3.1 Johnson and Johnson Non-oncology Biopharmaceuticals Basic Information
10.3.2 Johnson and Johnson Non-oncology Biopharmaceuticals Product Overview
10.3.3 Johnson and Johnson Non-oncology Biopharmaceuticals Product Market Performance
10.3.4 Johnson and Johnson Non-oncology Biopharmaceuticals SWOT Analysis
10.3.5 Johnson and Johnson Business Overview
10.3.6 Johnson and Johnson Recent Developments
10.4 Pfizer
10.4.1 Pfizer Non-oncology Biopharmaceuticals Basic Information
10.4.2 Pfizer Non-oncology Biopharmaceuticals Product Overview
10.4.3 Pfizer Non-oncology Biopharmaceuticals Product Market Performance
10.4.4 Pfizer Business Overview
10.4.5 Pfizer Recent Developments
10.5 Novo Nordisk
10.5.1 Novo Nordisk Non-oncology Biopharmaceuticals Basic Information
10.5.2 Novo Nordisk Non-oncology Biopharmaceuticals Product Overview
10.5.3 Novo Nordisk Non-oncology Biopharmaceuticals Product Market Performance
10.5.4 Novo Nordisk Business Overview
10.5.5 Novo Nordisk Recent Developments
10.6 Novartis
10.6.1 Novartis Non-oncology Biopharmaceuticals Basic Information
10.6.2 Novartis Non-oncology Biopharmaceuticals Product Overview
10.6.3 Novartis Non-oncology Biopharmaceuticals Product Market Performance
10.6.4 Novartis Business Overview
10.6.5 Novartis Recent Developments
10.7 Merck
10.7.1 Merck Non-oncology Biopharmaceuticals Basic Information
10.7.2 Merck Non-oncology Biopharmaceuticals Product Overview
10.7.3 Merck Non-oncology Biopharmaceuticals Product Market Performance
10.7.4 Merck Business Overview
10.7.5 Merck Recent Developments
10.8 Teva
10.8.1 Teva Non-oncology Biopharmaceuticals Basic Information
10.8.2 Teva Non-oncology Biopharmaceuticals Product Overview
10.8.3 Teva Non-oncology Biopharmaceuticals Product Market Performance
10.8.4 Teva Business Overview
10.8.5 Teva Recent Developments
10.9 Eli Lilly
10.9.1 Eli Lilly Non-oncology Biopharmaceuticals Basic Information
10.9.2 Eli Lilly Non-oncology Biopharmaceuticals Product Overview
10.9.3 Eli Lilly Non-oncology Biopharmaceuticals Product Market Performance
10.9.4 Eli Lilly Business Overview
10.9.5 Eli Lilly Recent Developments
10.10 Bristol-Myers Squibb
10.10.1 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Basic Information
10.10.2 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product Overview
10.10.3 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product Market Performance
10.10.4 Bristol-Myers Squibb Business Overview
10.10.5 Bristol-Myers Squibb Recent Developments
10.11 GlaxoSmithKline
10.11.1 GlaxoSmithKline Non-oncology Biopharmaceuticals Basic Information
10.11.2 GlaxoSmithKline Non-oncology Biopharmaceuticals Product Overview
10.11.3 GlaxoSmithKline Non-oncology Biopharmaceuticals Product Market Performance
10.11.4 GlaxoSmithKline Business Overview
10.11.5 GlaxoSmithKline Recent Developments
10.12 UCB Pharma
10.12.1 UCB Pharma Non-oncology Biopharmaceuticals Basic Information
10.12.2 UCB Pharma Non-oncology Biopharmaceuticals Product Overview
10.12.3 UCB Pharma Non-oncology Biopharmaceuticals Product Market Performance
10.12.4 UCB Pharma Business Overview
10.12.5 UCB Pharma Recent Developments
10.13 Amgen
10.13.1 Amgen Non-oncology Biopharmaceuticals Basic Information
10.13.2 Amgen Non-oncology Biopharmaceuticals Product Overview
10.13.3 Amgen Non-oncology Biopharmaceuticals Product Market Performance
10.13.4 Amgen Business Overview
10.13.5 Amgen Recent Developments
10.14 AbbVie
10.14.1 AbbVie Non-oncology Biopharmaceuticals Basic Information
10.14.2 AbbVie Non-oncology Biopharmaceuticals Product Overview
10.14.3 AbbVie Non-oncology Biopharmaceuticals Product Market Performance
10.14.4 AbbVie Business Overview
10.14.5 AbbVie Recent Developments
10.15 Takeda
10.15.1 Takeda Non-oncology Biopharmaceuticals Basic Information
10.15.2 Takeda Non-oncology Biopharmaceuticals Product Overview
10.15.3 Takeda Non-oncology Biopharmaceuticals Product Market Performance
10.15.4 Takeda Business Overview
10.15.5 Takeda Recent Developments
10.16 AstraZeneca
10.16.1 AstraZeneca Non-oncology Biopharmaceuticals Basic Information
10.16.2 AstraZeneca Non-oncology Biopharmaceuticals Product Overview
10.16.3 AstraZeneca Non-oncology Biopharmaceuticals Product Market Performance
10.16.4 AstraZeneca Business Overview
10.16.5 AstraZeneca Recent Developments
10.17 Mylan
10.17.1 Mylan Non-oncology Biopharmaceuticals Basic Information
10.17.2 Mylan Non-oncology Biopharmaceuticals Product Overview
10.17.3 Mylan Non-oncology Biopharmaceuticals Product Market Performance
10.17.4 Mylan Business Overview
10.17.5 Mylan Recent Developments
10.18 LEO Pharma
10.18.1 LEO Pharma Non-oncology Biopharmaceuticals Basic Information
10.18.2 LEO Pharma Non-oncology Biopharmaceuticals Product Overview
10.18.3 LEO Pharma Non-oncology Biopharmaceuticals Product Market Performance
10.18.4 LEO Pharma Business Overview
10.18.5 LEO Pharma Recent Developments
10.19 Boehringer Ingelheim
10.19.1 Boehringer Ingelheim Non-oncology Biopharmaceuticals Basic Information
10.19.2 Boehringer Ingelheim Non-oncology Biopharmaceuticals Product Overview
10.19.3 Boehringer Ingelheim Non-oncology Biopharmaceuticals Product Market Performance
10.19.4 Boehringer Ingelheim Business Overview
10.19.5 Boehringer Ingelheim Recent Developments
10.20 Alexion Pharmaceuticals
10.20.1 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Basic Information
10.20.2 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product Overview
10.20.3 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product Market Performance
10.20.4 Alexion Pharmaceuticals Business Overview
10.20.5 Alexion Pharmaceuticals Recent Developments
10.21 Elusys Therapeutics
10.21.1 Elusys Therapeutics Non-oncology Biopharmaceuticals Basic Information
10.21.2 Elusys Therapeutics Non-oncology Biopharmaceuticals Product Overview
10.21.3 Elusys Therapeutics Non-oncology Biopharmaceuticals Product Market Performance
10.21.4 Elusys Therapeutics Business Overview
10.21.5 Elusys Therapeutics Recent Developments
10.22 Swedish Orphan Biovitrum
10.22.1 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Basic Information
10.22.2 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product Overview
10.22.3 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product Market Performance
10.22.4 Swedish Orphan Biovitrum Business Overview
10.22.5 Swedish Orphan Biovitrum Recent Developments
10.23 Biogen
10.23.1 Biogen Non-oncology Biopharmaceuticals Basic Information
10.23.2 Biogen Non-oncology Biopharmaceuticals Product Overview
10.23.3 Biogen Non-oncology Biopharmaceuticals Product Market Performance
10.23.4 Biogen Business Overview
10.23.5 Biogen Recent Developments
11 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET FORECAST BY REGION
11.1 Global Non-oncology Biopharmaceuticals Market Size Forecast
11.2 Global Non-oncology Biopharmaceuticals Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Non-oncology Biopharmaceuticals Market Size Forecast by Country
11.2.3 Asia Pacific Non-oncology Biopharmaceuticals Market Size Forecast by Region
11.2.4 South America Non-oncology Biopharmaceuticals Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Non-oncology Biopharmaceuticals by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Non-oncology Biopharmaceuticals Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Non-oncology Biopharmaceuticals by Type (2025-2032)
12.1.2 Global Non-oncology Biopharmaceuticals Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Non-oncology Biopharmaceuticals by Type (2025-2032)
12.2 Global Non-oncology Biopharmaceuticals Market Forecast by Application (2025-2032)
12.2.1 Global Non-oncology Biopharmaceuticals Sales (K MT) Forecast by Application
12.2.2 Global Non-oncology Biopharmaceuticals Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Non-oncology Biopharmaceuticals
1.2 Key Market Segments
1.2.1 Non-oncology Biopharmaceuticals Segment by Type
1.2.2 Non-oncology Biopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Non-oncology Biopharmaceuticals Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Non-oncology Biopharmaceuticals Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Global Non-oncology Biopharmaceuticals Sales by Manufacturers (2019-2024)
3.2 Global Non-oncology Biopharmaceuticals Revenue Market Share by Manufacturers (2019-2024)
3.3 Non-oncology Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Non-oncology Biopharmaceuticals Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Non-oncology Biopharmaceuticals Sales Sites, Area Served, Product Type
3.6 Non-oncology Biopharmaceuticals Market Competitive Situation and Trends
3.6.1 Non-oncology Biopharmaceuticals Market Concentration Rate
3.6.2 Global 5 and 10 Largest Non-oncology Biopharmaceuticals Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NON-ONCOLOGY BIOPHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 Non-oncology Biopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NON-ONCOLOGY BIOPHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-oncology Biopharmaceuticals Sales Market Share by Type (2019-2024)
6.3 Global Non-oncology Biopharmaceuticals Market Size Market Share by Type (2019-2024)
6.4 Global Non-oncology Biopharmaceuticals Price by Type (2019-2024)
7 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-oncology Biopharmaceuticals Market Sales by Application (2019-2024)
7.3 Global Non-oncology Biopharmaceuticals Market Size (M USD) by Application (2019-2024)
7.4 Global Non-oncology Biopharmaceuticals Sales Growth Rate by Application (2019-2024)
8 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET CONSUMPTION BY REGION
8.1 Global Non-oncology Biopharmaceuticals Sales by Region
8.1.1 Global Non-oncology Biopharmaceuticals Sales by Region
8.1.2 Global Non-oncology Biopharmaceuticals Sales Market Share by Region
8.2 North America
8.2.1 North America Non-oncology Biopharmaceuticals Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Non-oncology Biopharmaceuticals Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Non-oncology Biopharmaceuticals Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Non-oncology Biopharmaceuticals Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Non-oncology Biopharmaceuticals Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET PRODUCTION BY REGION
9.1 Global Production of Non-oncology Biopharmaceuticals by Region (2019-2024)
9.2 Global Non-oncology Biopharmaceuticals Revenue Market Share by Region (2019-2024)
9.3 Global Non-oncology Biopharmaceuticals Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Non-oncology Biopharmaceuticals Production
9.4.1 North America Non-oncology Biopharmaceuticals Production Growth Rate (2019-2024)
9.4.2 North America Non-oncology Biopharmaceuticals Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Non-oncology Biopharmaceuticals Production
9.5.1 Europe Non-oncology Biopharmaceuticals Production Growth Rate (2019-2024)
9.5.2 Europe Non-oncology Biopharmaceuticals Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Non-oncology Biopharmaceuticals Production (2019-2024)
9.6.1 Japan Non-oncology Biopharmaceuticals Production Growth Rate (2019-2024)
9.6.2 Japan Non-oncology Biopharmaceuticals Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Non-oncology Biopharmaceuticals Production (2019-2024)
9.7.1 China Non-oncology Biopharmaceuticals Production Growth Rate (2019-2024)
9.7.2 China Non-oncology Biopharmaceuticals Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Roche
10.1.1 Roche Non-oncology Biopharmaceuticals Basic Information
10.1.2 Roche Non-oncology Biopharmaceuticals Product Overview
10.1.3 Roche Non-oncology Biopharmaceuticals Product Market Performance
10.1.4 Roche Business Overview
10.1.5 Roche Non-oncology Biopharmaceuticals SWOT Analysis
10.1.6 Roche Recent Developments
10.2 Sanofi
10.2.1 Sanofi Non-oncology Biopharmaceuticals Basic Information
10.2.2 Sanofi Non-oncology Biopharmaceuticals Product Overview
10.2.3 Sanofi Non-oncology Biopharmaceuticals Product Market Performance
10.2.4 Sanofi Business Overview
10.2.5 Sanofi Non-oncology Biopharmaceuticals SWOT Analysis
10.2.6 Sanofi Recent Developments
10.3 Johnson and Johnson
10.3.1 Johnson and Johnson Non-oncology Biopharmaceuticals Basic Information
10.3.2 Johnson and Johnson Non-oncology Biopharmaceuticals Product Overview
10.3.3 Johnson and Johnson Non-oncology Biopharmaceuticals Product Market Performance
10.3.4 Johnson and Johnson Non-oncology Biopharmaceuticals SWOT Analysis
10.3.5 Johnson and Johnson Business Overview
10.3.6 Johnson and Johnson Recent Developments
10.4 Pfizer
10.4.1 Pfizer Non-oncology Biopharmaceuticals Basic Information
10.4.2 Pfizer Non-oncology Biopharmaceuticals Product Overview
10.4.3 Pfizer Non-oncology Biopharmaceuticals Product Market Performance
10.4.4 Pfizer Business Overview
10.4.5 Pfizer Recent Developments
10.5 Novo Nordisk
10.5.1 Novo Nordisk Non-oncology Biopharmaceuticals Basic Information
10.5.2 Novo Nordisk Non-oncology Biopharmaceuticals Product Overview
10.5.3 Novo Nordisk Non-oncology Biopharmaceuticals Product Market Performance
10.5.4 Novo Nordisk Business Overview
10.5.5 Novo Nordisk Recent Developments
10.6 Novartis
10.6.1 Novartis Non-oncology Biopharmaceuticals Basic Information
10.6.2 Novartis Non-oncology Biopharmaceuticals Product Overview
10.6.3 Novartis Non-oncology Biopharmaceuticals Product Market Performance
10.6.4 Novartis Business Overview
10.6.5 Novartis Recent Developments
10.7 Merck
10.7.1 Merck Non-oncology Biopharmaceuticals Basic Information
10.7.2 Merck Non-oncology Biopharmaceuticals Product Overview
10.7.3 Merck Non-oncology Biopharmaceuticals Product Market Performance
10.7.4 Merck Business Overview
10.7.5 Merck Recent Developments
10.8 Teva
10.8.1 Teva Non-oncology Biopharmaceuticals Basic Information
10.8.2 Teva Non-oncology Biopharmaceuticals Product Overview
10.8.3 Teva Non-oncology Biopharmaceuticals Product Market Performance
10.8.4 Teva Business Overview
10.8.5 Teva Recent Developments
10.9 Eli Lilly
10.9.1 Eli Lilly Non-oncology Biopharmaceuticals Basic Information
10.9.2 Eli Lilly Non-oncology Biopharmaceuticals Product Overview
10.9.3 Eli Lilly Non-oncology Biopharmaceuticals Product Market Performance
10.9.4 Eli Lilly Business Overview
10.9.5 Eli Lilly Recent Developments
10.10 Bristol-Myers Squibb
10.10.1 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Basic Information
10.10.2 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product Overview
10.10.3 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product Market Performance
10.10.4 Bristol-Myers Squibb Business Overview
10.10.5 Bristol-Myers Squibb Recent Developments
10.11 GlaxoSmithKline
10.11.1 GlaxoSmithKline Non-oncology Biopharmaceuticals Basic Information
10.11.2 GlaxoSmithKline Non-oncology Biopharmaceuticals Product Overview
10.11.3 GlaxoSmithKline Non-oncology Biopharmaceuticals Product Market Performance
10.11.4 GlaxoSmithKline Business Overview
10.11.5 GlaxoSmithKline Recent Developments
10.12 UCB Pharma
10.12.1 UCB Pharma Non-oncology Biopharmaceuticals Basic Information
10.12.2 UCB Pharma Non-oncology Biopharmaceuticals Product Overview
10.12.3 UCB Pharma Non-oncology Biopharmaceuticals Product Market Performance
10.12.4 UCB Pharma Business Overview
10.12.5 UCB Pharma Recent Developments
10.13 Amgen
10.13.1 Amgen Non-oncology Biopharmaceuticals Basic Information
10.13.2 Amgen Non-oncology Biopharmaceuticals Product Overview
10.13.3 Amgen Non-oncology Biopharmaceuticals Product Market Performance
10.13.4 Amgen Business Overview
10.13.5 Amgen Recent Developments
10.14 AbbVie
10.14.1 AbbVie Non-oncology Biopharmaceuticals Basic Information
10.14.2 AbbVie Non-oncology Biopharmaceuticals Product Overview
10.14.3 AbbVie Non-oncology Biopharmaceuticals Product Market Performance
10.14.4 AbbVie Business Overview
10.14.5 AbbVie Recent Developments
10.15 Takeda
10.15.1 Takeda Non-oncology Biopharmaceuticals Basic Information
10.15.2 Takeda Non-oncology Biopharmaceuticals Product Overview
10.15.3 Takeda Non-oncology Biopharmaceuticals Product Market Performance
10.15.4 Takeda Business Overview
10.15.5 Takeda Recent Developments
10.16 AstraZeneca
10.16.1 AstraZeneca Non-oncology Biopharmaceuticals Basic Information
10.16.2 AstraZeneca Non-oncology Biopharmaceuticals Product Overview
10.16.3 AstraZeneca Non-oncology Biopharmaceuticals Product Market Performance
10.16.4 AstraZeneca Business Overview
10.16.5 AstraZeneca Recent Developments
10.17 Mylan
10.17.1 Mylan Non-oncology Biopharmaceuticals Basic Information
10.17.2 Mylan Non-oncology Biopharmaceuticals Product Overview
10.17.3 Mylan Non-oncology Biopharmaceuticals Product Market Performance
10.17.4 Mylan Business Overview
10.17.5 Mylan Recent Developments
10.18 LEO Pharma
10.18.1 LEO Pharma Non-oncology Biopharmaceuticals Basic Information
10.18.2 LEO Pharma Non-oncology Biopharmaceuticals Product Overview
10.18.3 LEO Pharma Non-oncology Biopharmaceuticals Product Market Performance
10.18.4 LEO Pharma Business Overview
10.18.5 LEO Pharma Recent Developments
10.19 Boehringer Ingelheim
10.19.1 Boehringer Ingelheim Non-oncology Biopharmaceuticals Basic Information
10.19.2 Boehringer Ingelheim Non-oncology Biopharmaceuticals Product Overview
10.19.3 Boehringer Ingelheim Non-oncology Biopharmaceuticals Product Market Performance
10.19.4 Boehringer Ingelheim Business Overview
10.19.5 Boehringer Ingelheim Recent Developments
10.20 Alexion Pharmaceuticals
10.20.1 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Basic Information
10.20.2 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product Overview
10.20.3 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product Market Performance
10.20.4 Alexion Pharmaceuticals Business Overview
10.20.5 Alexion Pharmaceuticals Recent Developments
10.21 Elusys Therapeutics
10.21.1 Elusys Therapeutics Non-oncology Biopharmaceuticals Basic Information
10.21.2 Elusys Therapeutics Non-oncology Biopharmaceuticals Product Overview
10.21.3 Elusys Therapeutics Non-oncology Biopharmaceuticals Product Market Performance
10.21.4 Elusys Therapeutics Business Overview
10.21.5 Elusys Therapeutics Recent Developments
10.22 Swedish Orphan Biovitrum
10.22.1 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Basic Information
10.22.2 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product Overview
10.22.3 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product Market Performance
10.22.4 Swedish Orphan Biovitrum Business Overview
10.22.5 Swedish Orphan Biovitrum Recent Developments
10.23 Biogen
10.23.1 Biogen Non-oncology Biopharmaceuticals Basic Information
10.23.2 Biogen Non-oncology Biopharmaceuticals Product Overview
10.23.3 Biogen Non-oncology Biopharmaceuticals Product Market Performance
10.23.4 Biogen Business Overview
10.23.5 Biogen Recent Developments
11 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET FORECAST BY REGION
11.1 Global Non-oncology Biopharmaceuticals Market Size Forecast
11.2 Global Non-oncology Biopharmaceuticals Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Non-oncology Biopharmaceuticals Market Size Forecast by Country
11.2.3 Asia Pacific Non-oncology Biopharmaceuticals Market Size Forecast by Region
11.2.4 South America Non-oncology Biopharmaceuticals Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Non-oncology Biopharmaceuticals by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Non-oncology Biopharmaceuticals Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Non-oncology Biopharmaceuticals by Type (2025-2032)
12.1.2 Global Non-oncology Biopharmaceuticals Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Non-oncology Biopharmaceuticals by Type (2025-2032)
12.2 Global Non-oncology Biopharmaceuticals Market Forecast by Application (2025-2032)
12.2.1 Global Non-oncology Biopharmaceuticals Sales (K MT) Forecast by Application
12.2.2 Global Non-oncology Biopharmaceuticals Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Non-oncology Biopharmaceuticals Market Size Comparison by Region (M USD)
Table 5. Global Non-oncology Biopharmaceuticals Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Non-oncology Biopharmaceuticals Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Non-oncology Biopharmaceuticals Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Non-oncology Biopharmaceuticals Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-oncology Biopharmaceuticals as of 2022)
Table 10. Global Market Non-oncology Biopharmaceuticals Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Non-oncology Biopharmaceuticals Sales Sites and Area Served
Table 12. Manufacturers Non-oncology Biopharmaceuticals Product Type
Table 13. Global Non-oncology Biopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Non-oncology Biopharmaceuticals
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Non-oncology Biopharmaceuticals Market Challenges
Table 22. Global Non-oncology Biopharmaceuticals Sales by Type (K MT)
Table 23. Global Non-oncology Biopharmaceuticals Market Size by Type (M USD)
Table 24. Global Non-oncology Biopharmaceuticals Sales (K MT) by Type (2019-2024)
Table 25. Global Non-oncology Biopharmaceuticals Sales Market Share by Type (2019-2024)
Table 26. Global Non-oncology Biopharmaceuticals Market Size (M USD) by Type (2019-2024)
Table 27. Global Non-oncology Biopharmaceuticals Market Size Share by Type (2019-2024)
Table 28. Global Non-oncology Biopharmaceuticals Price (USD/MT) by Type (2019-2024)
Table 29. Global Non-oncology Biopharmaceuticals Sales (K MT) by Application
Table 30. Global Non-oncology Biopharmaceuticals Market Size by Application
Table 31. Global Non-oncology Biopharmaceuticals Sales by Application (2019-2024) & (K MT)
Table 32. Global Non-oncology Biopharmaceuticals Sales Market Share by Application (2019-2024)
Table 33. Global Non-oncology Biopharmaceuticals Sales by Application (2019-2024) & (M USD)
Table 34. Global Non-oncology Biopharmaceuticals Market Share by Application (2019-2024)
Table 35. Global Non-oncology Biopharmaceuticals Sales Growth Rate by Application (2019-2024)
Table 36. Global Non-oncology Biopharmaceuticals Sales by Region (2019-2024) & (K MT)
Table 37. Global Non-oncology Biopharmaceuticals Sales Market Share by Region (2019-2024)
Table 38. North America Non-oncology Biopharmaceuticals Sales by Country (2019-2024) & (K MT)
Table 39. Europe Non-oncology Biopharmaceuticals Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Non-oncology Biopharmaceuticals Sales by Region (2019-2024) & (K MT)
Table 41. South America Non-oncology Biopharmaceuticals Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Non-oncology Biopharmaceuticals Sales by Region (2019-2024) & (K MT)
Table 43. Global Non-oncology Biopharmaceuticals Production (K MT) by Region (2019-2024)
Table 44. Global Non-oncology Biopharmaceuticals Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Non-oncology Biopharmaceuticals Revenue Market Share by Region (2019-2024)
Table 46. Global Non-oncology Biopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Non-oncology Biopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Non-oncology Biopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Non-oncology Biopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Non-oncology Biopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Roche Non-oncology Biopharmaceuticals Basic Information
Table 52. Roche Non-oncology Biopharmaceuticals Product Overview
Table 53. Roche Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Roche Business Overview
Table 55. Roche Non-oncology Biopharmaceuticals SWOT Analysis
Table 56. Roche Recent Developments
Table 57. Sanofi Non-oncology Biopharmaceuticals Basic Information
Table 58. Sanofi Non-oncology Biopharmaceuticals Product Overview
Table 59. Sanofi Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Sanofi Business Overview
Table 61. Sanofi Non-oncology Biopharmaceuticals SWOT Analysis
Table 62. Sanofi Recent Developments
Table 63. Johnson and Johnson Non-oncology Biopharmaceuticals Basic Information
Table 64. Johnson and Johnson Non-oncology Biopharmaceuticals Product Overview
Table 65. Johnson and Johnson Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Johnson and Johnson Non-oncology Biopharmaceuticals SWOT Analysis
Table 67. Johnson and Johnson Business Overview
Table 68. Johnson and Johnson Recent Developments
Table 69. Pfizer Non-oncology Biopharmaceuticals Basic Information
Table 70. Pfizer Non-oncology Biopharmaceuticals Product Overview
Table 71. Pfizer Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Pfizer Business Overview
Table 73. Pfizer Recent Developments
Table 74. Novo Nordisk Non-oncology Biopharmaceuticals Basic Information
Table 75. Novo Nordisk Non-oncology Biopharmaceuticals Product Overview
Table 76. Novo Nordisk Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Novo Nordisk Business Overview
Table 78. Novo Nordisk Recent Developments
Table 79. Novartis Non-oncology Biopharmaceuticals Basic Information
Table 80. Novartis Non-oncology Biopharmaceuticals Product Overview
Table 81. Novartis Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Novartis Business Overview
Table 83. Novartis Recent Developments
Table 84. Merck Non-oncology Biopharmaceuticals Basic Information
Table 85. Merck Non-oncology Biopharmaceuticals Product Overview
Table 86. Merck Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Merck Business Overview
Table 88. Merck Recent Developments
Table 89. Teva Non-oncology Biopharmaceuticals Basic Information
Table 90. Teva Non-oncology Biopharmaceuticals Product Overview
Table 91. Teva Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Teva Business Overview
Table 93. Teva Recent Developments
Table 94. Eli Lilly Non-oncology Biopharmaceuticals Basic Information
Table 95. Eli Lilly Non-oncology Biopharmaceuticals Product Overview
Table 96. Eli Lilly Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Eli Lilly Business Overview
Table 98. Eli Lilly Recent Developments
Table 99. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Basic Information
Table 100. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product Overview
Table 101. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Bristol-Myers Squibb Business Overview
Table 103. Bristol-Myers Squibb Recent Developments
Table 104. GlaxoSmithKline Non-oncology Biopharmaceuticals Basic Information
Table 105. GlaxoSmithKline Non-oncology Biopharmaceuticals Product Overview
Table 106. GlaxoSmithKline Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. GlaxoSmithKline Business Overview
Table 108. GlaxoSmithKline Recent Developments
Table 109. UCB Pharma Non-oncology Biopharmaceuticals Basic Information
Table 110. UCB Pharma Non-oncology Biopharmaceuticals Product Overview
Table 111. UCB Pharma Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. UCB Pharma Business Overview
Table 113. UCB Pharma Recent Developments
Table 114. Amgen Non-oncology Biopharmaceuticals Basic Information
Table 115. Amgen Non-oncology Biopharmaceuticals Product Overview
Table 116. Amgen Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Amgen Business Overview
Table 118. Amgen Recent Developments
Table 119. AbbVie Non-oncology Biopharmaceuticals Basic Information
Table 120. AbbVie Non-oncology Biopharmaceuticals Product Overview
Table 121. AbbVie Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. AbbVie Business Overview
Table 123. AbbVie Recent Developments
Table 124. Takeda Non-oncology Biopharmaceuticals Basic Information
Table 125. Takeda Non-oncology Biopharmaceuticals Product Overview
Table 126. Takeda Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Takeda Business Overview
Table 128. Takeda Recent Developments
Table 129. AstraZeneca Non-oncology Biopharmaceuticals Basic Information
Table 130. AstraZeneca Non-oncology Biopharmaceuticals Product Overview
Table 131. AstraZeneca Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. AstraZeneca Business Overview
Table 133. AstraZeneca Recent Developments
Table 134. Mylan Non-oncology Biopharmaceuticals Basic Information
Table 135. Mylan Non-oncology Biopharmaceuticals Product Overview
Table 136. Mylan Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 137. Mylan Business Overview
Table 138. Mylan Recent Developments
Table 139. LEO Pharma Non-oncology Biopharmaceuticals Basic Information
Table 140. LEO Pharma Non-oncology Biopharmaceuticals Product Overview
Table 141. LEO Pharma Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 142. LEO Pharma Business Overview
Table 143. LEO Pharma Recent Developments
Table 144. Boehringer Ingelheim Non-oncology Biopharmaceuticals Basic Information
Table 145. Boehringer Ingelheim Non-oncology Biopharmaceuticals Product Overview
Table 146. Boehringer Ingelheim Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 147. Boehringer Ingelheim Business Overview
Table 148. Boehringer Ingelheim Recent Developments
Table 149. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Basic Information
Table 150. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product Overview
Table 151. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 152. Alexion Pharmaceuticals Business Overview
Table 153. Alexion Pharmaceuticals Recent Developments
Table 154. Elusys Therapeutics Non-oncology Biopharmaceuticals Basic Information
Table 155. Elusys Therapeutics Non-oncology Biopharmaceuticals Product Overview
Table 156. Elusys Therapeutics Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 157. Elusys Therapeutics Business Overview
Table 158. Elusys Therapeutics Recent Developments
Table 159. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Basic Information
Table 160. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product Overview
Table 161. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 162. Swedish Orphan Biovitrum Business Overview
Table 163. Swedish Orphan Biovitrum Recent Developments
Table 164. Biogen Non-oncology Biopharmaceuticals Basic Information
Table 165. Biogen Non-oncology Biopharmaceuticals Product Overview
Table 166. Biogen Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 167. Biogen Business Overview
Table 168. Biogen Recent Developments
Table 169. Global Non-oncology Biopharmaceuticals Sales Forecast by Region (2025-2032) & (K MT)
Table 170. Global Non-oncology Biopharmaceuticals Market Size Forecast by Region (2025-2032) & (M USD)
Table 171. North America Non-oncology Biopharmaceuticals Sales Forecast by Country (2025-2032) & (K MT)
Table 172. North America Non-oncology Biopharmaceuticals Market Size Forecast by Country (2025-2032) & (M USD)
Table 173. Europe Non-oncology Biopharmaceuticals Sales Forecast by Country (2025-2032) & (K MT)
Table 174. Europe Non-oncology Biopharmaceuticals Market Size Forecast by Country (2025-2032) & (M USD)
Table 175. Asia Pacific Non-oncology Biopharmaceuticals Sales Forecast by Region (2025-2032) & (K MT)
Table 176. Asia Pacific Non-oncology Biopharmaceuticals Market Size Forecast by Region (2025-2032) & (M USD)
Table 177. South America Non-oncology Biopharmaceuticals Sales Forecast by Country (2025-2032) & (K MT)
Table 178. South America Non-oncology Biopharmaceuticals Market Size Forecast by Country (2025-2032) & (M USD)
Table 179. Middle East and Africa Non-oncology Biopharmaceuticals Consumption Forecast by Country (2025-2032) & (Units)
Table 180. Middle East and Africa Non-oncology Biopharmaceuticals Market Size Forecast by Country (2025-2032) & (M USD)
Table 181. Global Non-oncology Biopharmaceuticals Sales Forecast by Type (2025-2032) & (K MT)
Table 182. Global Non-oncology Biopharmaceuticals Market Size Forecast by Type (2025-2032) & (M USD)
Table 183. Global Non-oncology Biopharmaceuticals Price Forecast by Type (2025-2032) & (USD/MT)
Table 184. Global Non-oncology Biopharmaceuticals Sales (K MT) Forecast by Application (2025-2032)
Table 185. Global Non-oncology Biopharmaceuticals Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Non-oncology Biopharmaceuticals Market Size Comparison by Region (M USD)
Table 5. Global Non-oncology Biopharmaceuticals Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Non-oncology Biopharmaceuticals Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Non-oncology Biopharmaceuticals Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Non-oncology Biopharmaceuticals Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-oncology Biopharmaceuticals as of 2022)
Table 10. Global Market Non-oncology Biopharmaceuticals Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Non-oncology Biopharmaceuticals Sales Sites and Area Served
Table 12. Manufacturers Non-oncology Biopharmaceuticals Product Type
Table 13. Global Non-oncology Biopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Non-oncology Biopharmaceuticals
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Non-oncology Biopharmaceuticals Market Challenges
Table 22. Global Non-oncology Biopharmaceuticals Sales by Type (K MT)
Table 23. Global Non-oncology Biopharmaceuticals Market Size by Type (M USD)
Table 24. Global Non-oncology Biopharmaceuticals Sales (K MT) by Type (2019-2024)
Table 25. Global Non-oncology Biopharmaceuticals Sales Market Share by Type (2019-2024)
Table 26. Global Non-oncology Biopharmaceuticals Market Size (M USD) by Type (2019-2024)
Table 27. Global Non-oncology Biopharmaceuticals Market Size Share by Type (2019-2024)
Table 28. Global Non-oncology Biopharmaceuticals Price (USD/MT) by Type (2019-2024)
Table 29. Global Non-oncology Biopharmaceuticals Sales (K MT) by Application
Table 30. Global Non-oncology Biopharmaceuticals Market Size by Application
Table 31. Global Non-oncology Biopharmaceuticals Sales by Application (2019-2024) & (K MT)
Table 32. Global Non-oncology Biopharmaceuticals Sales Market Share by Application (2019-2024)
Table 33. Global Non-oncology Biopharmaceuticals Sales by Application (2019-2024) & (M USD)
Table 34. Global Non-oncology Biopharmaceuticals Market Share by Application (2019-2024)
Table 35. Global Non-oncology Biopharmaceuticals Sales Growth Rate by Application (2019-2024)
Table 36. Global Non-oncology Biopharmaceuticals Sales by Region (2019-2024) & (K MT)
Table 37. Global Non-oncology Biopharmaceuticals Sales Market Share by Region (2019-2024)
Table 38. North America Non-oncology Biopharmaceuticals Sales by Country (2019-2024) & (K MT)
Table 39. Europe Non-oncology Biopharmaceuticals Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Non-oncology Biopharmaceuticals Sales by Region (2019-2024) & (K MT)
Table 41. South America Non-oncology Biopharmaceuticals Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Non-oncology Biopharmaceuticals Sales by Region (2019-2024) & (K MT)
Table 43. Global Non-oncology Biopharmaceuticals Production (K MT) by Region (2019-2024)
Table 44. Global Non-oncology Biopharmaceuticals Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Non-oncology Biopharmaceuticals Revenue Market Share by Region (2019-2024)
Table 46. Global Non-oncology Biopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Non-oncology Biopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Non-oncology Biopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Non-oncology Biopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Non-oncology Biopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Roche Non-oncology Biopharmaceuticals Basic Information
Table 52. Roche Non-oncology Biopharmaceuticals Product Overview
Table 53. Roche Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Roche Business Overview
Table 55. Roche Non-oncology Biopharmaceuticals SWOT Analysis
Table 56. Roche Recent Developments
Table 57. Sanofi Non-oncology Biopharmaceuticals Basic Information
Table 58. Sanofi Non-oncology Biopharmaceuticals Product Overview
Table 59. Sanofi Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Sanofi Business Overview
Table 61. Sanofi Non-oncology Biopharmaceuticals SWOT Analysis
Table 62. Sanofi Recent Developments
Table 63. Johnson and Johnson Non-oncology Biopharmaceuticals Basic Information
Table 64. Johnson and Johnson Non-oncology Biopharmaceuticals Product Overview
Table 65. Johnson and Johnson Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Johnson and Johnson Non-oncology Biopharmaceuticals SWOT Analysis
Table 67. Johnson and Johnson Business Overview
Table 68. Johnson and Johnson Recent Developments
Table 69. Pfizer Non-oncology Biopharmaceuticals Basic Information
Table 70. Pfizer Non-oncology Biopharmaceuticals Product Overview
Table 71. Pfizer Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Pfizer Business Overview
Table 73. Pfizer Recent Developments
Table 74. Novo Nordisk Non-oncology Biopharmaceuticals Basic Information
Table 75. Novo Nordisk Non-oncology Biopharmaceuticals Product Overview
Table 76. Novo Nordisk Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Novo Nordisk Business Overview
Table 78. Novo Nordisk Recent Developments
Table 79. Novartis Non-oncology Biopharmaceuticals Basic Information
Table 80. Novartis Non-oncology Biopharmaceuticals Product Overview
Table 81. Novartis Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Novartis Business Overview
Table 83. Novartis Recent Developments
Table 84. Merck Non-oncology Biopharmaceuticals Basic Information
Table 85. Merck Non-oncology Biopharmaceuticals Product Overview
Table 86. Merck Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Merck Business Overview
Table 88. Merck Recent Developments
Table 89. Teva Non-oncology Biopharmaceuticals Basic Information
Table 90. Teva Non-oncology Biopharmaceuticals Product Overview
Table 91. Teva Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Teva Business Overview
Table 93. Teva Recent Developments
Table 94. Eli Lilly Non-oncology Biopharmaceuticals Basic Information
Table 95. Eli Lilly Non-oncology Biopharmaceuticals Product Overview
Table 96. Eli Lilly Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Eli Lilly Business Overview
Table 98. Eli Lilly Recent Developments
Table 99. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Basic Information
Table 100. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product Overview
Table 101. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Bristol-Myers Squibb Business Overview
Table 103. Bristol-Myers Squibb Recent Developments
Table 104. GlaxoSmithKline Non-oncology Biopharmaceuticals Basic Information
Table 105. GlaxoSmithKline Non-oncology Biopharmaceuticals Product Overview
Table 106. GlaxoSmithKline Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. GlaxoSmithKline Business Overview
Table 108. GlaxoSmithKline Recent Developments
Table 109. UCB Pharma Non-oncology Biopharmaceuticals Basic Information
Table 110. UCB Pharma Non-oncology Biopharmaceuticals Product Overview
Table 111. UCB Pharma Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. UCB Pharma Business Overview
Table 113. UCB Pharma Recent Developments
Table 114. Amgen Non-oncology Biopharmaceuticals Basic Information
Table 115. Amgen Non-oncology Biopharmaceuticals Product Overview
Table 116. Amgen Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Amgen Business Overview
Table 118. Amgen Recent Developments
Table 119. AbbVie Non-oncology Biopharmaceuticals Basic Information
Table 120. AbbVie Non-oncology Biopharmaceuticals Product Overview
Table 121. AbbVie Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. AbbVie Business Overview
Table 123. AbbVie Recent Developments
Table 124. Takeda Non-oncology Biopharmaceuticals Basic Information
Table 125. Takeda Non-oncology Biopharmaceuticals Product Overview
Table 126. Takeda Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Takeda Business Overview
Table 128. Takeda Recent Developments
Table 129. AstraZeneca Non-oncology Biopharmaceuticals Basic Information
Table 130. AstraZeneca Non-oncology Biopharmaceuticals Product Overview
Table 131. AstraZeneca Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. AstraZeneca Business Overview
Table 133. AstraZeneca Recent Developments
Table 134. Mylan Non-oncology Biopharmaceuticals Basic Information
Table 135. Mylan Non-oncology Biopharmaceuticals Product Overview
Table 136. Mylan Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 137. Mylan Business Overview
Table 138. Mylan Recent Developments
Table 139. LEO Pharma Non-oncology Biopharmaceuticals Basic Information
Table 140. LEO Pharma Non-oncology Biopharmaceuticals Product Overview
Table 141. LEO Pharma Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 142. LEO Pharma Business Overview
Table 143. LEO Pharma Recent Developments
Table 144. Boehringer Ingelheim Non-oncology Biopharmaceuticals Basic Information
Table 145. Boehringer Ingelheim Non-oncology Biopharmaceuticals Product Overview
Table 146. Boehringer Ingelheim Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 147. Boehringer Ingelheim Business Overview
Table 148. Boehringer Ingelheim Recent Developments
Table 149. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Basic Information
Table 150. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product Overview
Table 151. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 152. Alexion Pharmaceuticals Business Overview
Table 153. Alexion Pharmaceuticals Recent Developments
Table 154. Elusys Therapeutics Non-oncology Biopharmaceuticals Basic Information
Table 155. Elusys Therapeutics Non-oncology Biopharmaceuticals Product Overview
Table 156. Elusys Therapeutics Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 157. Elusys Therapeutics Business Overview
Table 158. Elusys Therapeutics Recent Developments
Table 159. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Basic Information
Table 160. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product Overview
Table 161. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 162. Swedish Orphan Biovitrum Business Overview
Table 163. Swedish Orphan Biovitrum Recent Developments
Table 164. Biogen Non-oncology Biopharmaceuticals Basic Information
Table 165. Biogen Non-oncology Biopharmaceuticals Product Overview
Table 166. Biogen Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 167. Biogen Business Overview
Table 168. Biogen Recent Developments
Table 169. Global Non-oncology Biopharmaceuticals Sales Forecast by Region (2025-2032) & (K MT)
Table 170. Global Non-oncology Biopharmaceuticals Market Size Forecast by Region (2025-2032) & (M USD)
Table 171. North America Non-oncology Biopharmaceuticals Sales Forecast by Country (2025-2032) & (K MT)
Table 172. North America Non-oncology Biopharmaceuticals Market Size Forecast by Country (2025-2032) & (M USD)
Table 173. Europe Non-oncology Biopharmaceuticals Sales Forecast by Country (2025-2032) & (K MT)
Table 174. Europe Non-oncology Biopharmaceuticals Market Size Forecast by Country (2025-2032) & (M USD)
Table 175. Asia Pacific Non-oncology Biopharmaceuticals Sales Forecast by Region (2025-2032) & (K MT)
Table 176. Asia Pacific Non-oncology Biopharmaceuticals Market Size Forecast by Region (2025-2032) & (M USD)
Table 177. South America Non-oncology Biopharmaceuticals Sales Forecast by Country (2025-2032) & (K MT)
Table 178. South America Non-oncology Biopharmaceuticals Market Size Forecast by Country (2025-2032) & (M USD)
Table 179. Middle East and Africa Non-oncology Biopharmaceuticals Consumption Forecast by Country (2025-2032) & (Units)
Table 180. Middle East and Africa Non-oncology Biopharmaceuticals Market Size Forecast by Country (2025-2032) & (M USD)
Table 181. Global Non-oncology Biopharmaceuticals Sales Forecast by Type (2025-2032) & (K MT)
Table 182. Global Non-oncology Biopharmaceuticals Market Size Forecast by Type (2025-2032) & (M USD)
Table 183. Global Non-oncology Biopharmaceuticals Price Forecast by Type (2025-2032) & (USD/MT)
Table 184. Global Non-oncology Biopharmaceuticals Sales (K MT) Forecast by Application (2025-2032)
Table 185. Global Non-oncology Biopharmaceuticals Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Non-oncology Biopharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non-oncology Biopharmaceuticals Market Size (M USD), 2019-2032
Figure 5. Global Non-oncology Biopharmaceuticals Market Size (M USD) (2019-2032)
Figure 6. Global Non-oncology Biopharmaceuticals Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Non-oncology Biopharmaceuticals Market Size by Country (M USD)
Figure 11. Non-oncology Biopharmaceuticals Sales Share by Manufacturers in 2023
Figure 12. Global Non-oncology Biopharmaceuticals Revenue Share by Manufacturers in 2023
Figure 13. Non-oncology Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Non-oncology Biopharmaceuticals Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Non-oncology Biopharmaceuticals Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Non-oncology Biopharmaceuticals Market Share by Type
Figure 18. Sales Market Share of Non-oncology Biopharmaceuticals by Type (2019-2024)
Figure 19. Sales Market Share of Non-oncology Biopharmaceuticals by Type in 2023
Figure 20. Market Size Share of Non-oncology Biopharmaceuticals by Type (2019-2024)
Figure 21. Market Size Market Share of Non-oncology Biopharmaceuticals by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Non-oncology Biopharmaceuticals Market Share by Application
Figure 24. Global Non-oncology Biopharmaceuticals Sales Market Share by Application (2019-2024)
Figure 25. Global Non-oncology Biopharmaceuticals Sales Market Share by Application in 2023
Figure 26. Global Non-oncology Biopharmaceuticals Market Share by Application (2019-2024)
Figure 27. Global Non-oncology Biopharmaceuticals Market Share by Application in 2023
Figure 28. Global Non-oncology Biopharmaceuticals Sales Growth Rate by Application (2019-2024)
Figure 29. Global Non-oncology Biopharmaceuticals Sales Market Share by Region (2019-2024)
Figure 30. North America Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Non-oncology Biopharmaceuticals Sales Market Share by Country in 2023
Figure 32. U.S. Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Non-oncology Biopharmaceuticals Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Non-oncology Biopharmaceuticals Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Non-oncology Biopharmaceuticals Sales Market Share by Country in 2023
Figure 37. Germany Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Non-oncology Biopharmaceuticals Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Non-oncology Biopharmaceuticals Sales Market Share by Region in 2023
Figure 44. China Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Non-oncology Biopharmaceuticals Sales and Growth Rate (K MT)
Figure 50. South America Non-oncology Biopharmaceuticals Sales Market Share by Country in 2023
Figure 51. Brazil Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Non-oncology Biopharmaceuticals Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Non-oncology Biopharmaceuticals Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Non-oncology Biopharmaceuticals Production Market Share by Region (2019-2024)
Figure 62. North America Non-oncology Biopharmaceuticals Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Non-oncology Biopharmaceuticals Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Non-oncology Biopharmaceuticals Production (K MT) Growth Rate (2019-2024)
Figure 65. China Non-oncology Biopharmaceuticals Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Non-oncology Biopharmaceuticals Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Non-oncology Biopharmaceuticals Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Non-oncology Biopharmaceuticals Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Non-oncology Biopharmaceuticals Market Share Forecast by Type (2025-2032)
Figure 70. Global Non-oncology Biopharmaceuticals Sales Forecast by Application (2025-2032)
Figure 71. Global Non-oncology Biopharmaceuticals Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Non-oncology Biopharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non-oncology Biopharmaceuticals Market Size (M USD), 2019-2032
Figure 5. Global Non-oncology Biopharmaceuticals Market Size (M USD) (2019-2032)
Figure 6. Global Non-oncology Biopharmaceuticals Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Non-oncology Biopharmaceuticals Market Size by Country (M USD)
Figure 11. Non-oncology Biopharmaceuticals Sales Share by Manufacturers in 2023
Figure 12. Global Non-oncology Biopharmaceuticals Revenue Share by Manufacturers in 2023
Figure 13. Non-oncology Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Non-oncology Biopharmaceuticals Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Non-oncology Biopharmaceuticals Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Non-oncology Biopharmaceuticals Market Share by Type
Figure 18. Sales Market Share of Non-oncology Biopharmaceuticals by Type (2019-2024)
Figure 19. Sales Market Share of Non-oncology Biopharmaceuticals by Type in 2023
Figure 20. Market Size Share of Non-oncology Biopharmaceuticals by Type (2019-2024)
Figure 21. Market Size Market Share of Non-oncology Biopharmaceuticals by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Non-oncology Biopharmaceuticals Market Share by Application
Figure 24. Global Non-oncology Biopharmaceuticals Sales Market Share by Application (2019-2024)
Figure 25. Global Non-oncology Biopharmaceuticals Sales Market Share by Application in 2023
Figure 26. Global Non-oncology Biopharmaceuticals Market Share by Application (2019-2024)
Figure 27. Global Non-oncology Biopharmaceuticals Market Share by Application in 2023
Figure 28. Global Non-oncology Biopharmaceuticals Sales Growth Rate by Application (2019-2024)
Figure 29. Global Non-oncology Biopharmaceuticals Sales Market Share by Region (2019-2024)
Figure 30. North America Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Non-oncology Biopharmaceuticals Sales Market Share by Country in 2023
Figure 32. U.S. Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Non-oncology Biopharmaceuticals Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Non-oncology Biopharmaceuticals Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Non-oncology Biopharmaceuticals Sales Market Share by Country in 2023
Figure 37. Germany Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Non-oncology Biopharmaceuticals Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Non-oncology Biopharmaceuticals Sales Market Share by Region in 2023
Figure 44. China Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Non-oncology Biopharmaceuticals Sales and Growth Rate (K MT)
Figure 50. South America Non-oncology Biopharmaceuticals Sales Market Share by Country in 2023
Figure 51. Brazil Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Non-oncology Biopharmaceuticals Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Non-oncology Biopharmaceuticals Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Non-oncology Biopharmaceuticals Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Non-oncology Biopharmaceuticals Production Market Share by Region (2019-2024)
Figure 62. North America Non-oncology Biopharmaceuticals Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Non-oncology Biopharmaceuticals Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Non-oncology Biopharmaceuticals Production (K MT) Growth Rate (2019-2024)
Figure 65. China Non-oncology Biopharmaceuticals Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Non-oncology Biopharmaceuticals Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Non-oncology Biopharmaceuticals Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Non-oncology Biopharmaceuticals Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Non-oncology Biopharmaceuticals Market Share Forecast by Type (2025-2032)
Figure 70. Global Non-oncology Biopharmaceuticals Sales Forecast by Application (2025-2032)
Figure 71. Global Non-oncology Biopharmaceuticals Market Share Forecast by Application (2025-2032)
